Immunogen reported $437.66M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abbvie ABBV:US $ 6098M 3648M
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Amgen AMGN:US $ 6528M 1461M
Astellas Pharma 4503:JP Y 315986M 34227M
AstraZeneca AZN:LN 5762M 567M
Bluebird Bio BLUE:US $ 106.26M 54.9M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Emergent Biosolutions EBS:US $ 435.8M 140.3M
Exelixis EXEL:US $ 723.27M 76.1M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Immunogen IMGN:US $ 437.66M 41.09M
Intrexon XON:US $ 40.32M 2.6M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Macrogenics MGNX:US $ 47.33M 76.14M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Novartis NVS:US $ 13852M 1445M
Pfizer PFE:US $ 2470M 526M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Seattle Genetics SGEN:US $ 261M 163.84M